Atlas Trials

A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Clinical trial NCT01288911 · COMPLETED

Trial details

NCT number
NCT01288911
Sponsor
Astellas Pharma Inc
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Prostatic Neoplasms
Start date
2011-03-22
Primary completion
2014-10-19
Enrollment
375

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.